To identify an accurate and reproducible method to define myocardial infarct (MI) size, we conducted a study in a closed-chest canine model of acute myocardial infarction, in which MI size was measured using different thresholding techniques and by imaging at different delay times after contrast administration. BACKGROUND The MI size by contrast-enhanced magnetic resonance imaging (CE-MRI) is directly related to long-term prognosis. However, previous measurements were done using nonuniform methods and tended to overestimate nonviable areas.
The extent of injury after an ischemic event and the distinction between viable and nonviable myocardium are important for treatment decision-making. Contrastenhanced (CE) magnetic resonance imaging (MRI) is an imaging modality capable of high spatial resolution and able to assess the presence of viable myocardium in infarcted and poor contractile areas (1) . In the chronic phase of myocardial infarction (MI), delayed hyperenhancement has been shown to correlate well with fibrosis and be a marker of irreversible injury (2) . Also, measurements of MI extent determined by CE-MRI have been demonstrated to predict long-term prognosis and play a key role in treatment (3, 4) .
Various studies have shown that in the acute MI, CE imaging techniques tend to overestimate nonviable tissue (5) (6) (7) (8) (9) . Many technical issues appear to be involved in this process. Previous studies using CE-MRI have utilized different methods, different pulse sequences for imaging acquisition, as well as different delays after contrast injection, making interpretation complex (1, 5, 6) . Recently, a link between infarct overestimation and the delay time of imaging acquisition after contrast injection has been proposed (9) . However, other previous studies have produced data suggesting that infarct size is reproducible between 10 and 30 min after contrast administration (10) . The discrepancies observed between those studies could be attributed to methodologic differences and imply the need for an accurate and objective technique to define the extent of a delayed hyperenhanced region. Most studies have used arbitrary criteria to define the extent of infarcted tissue from CE-MRI (5, 9, 11) . Until now, no one has validated an ideal technique to define infarct size by CE-MRI.
This study represents an attempt to find a uniform method to measure infarct size from delayed CE images.
For this purpose, we conducted a study with two main objectives: 1) to determine the most accurate and objective thresholding criterion to assess the presence and extent of viable myocardium in the acute phase of MI by delayed CE-MRI images; and 2) to examine whether the size of a hyperenhanced area remains constant as a function of time.
METHODS
Experimental protocol. All animal studies were approved by our Institutional Animal Care and Use Committee and complied with the "Guidelines for the Care and Use of Laboratory Animals" (National Institutes of Health [NIH] publication no. 80-23, revised 1985). Thirteen mongrel dogs (25 to 30 kg) were anesthetized, intubated, and mechanically ventilated. All animals received prophylaxis with antibiotics every 4 h. Experimental MI. Catheter sheaths were placed in the right femoral artery (10-F) and right carotid artery (8-F). After this, the animals underwent heparinization (5,000 IU intravenously). A 6-F pigtail catheter was advanced through the femoral artery into the left ventricular (LV) cavity for ventriculography and pressure monitoring. A coronary angioplasty balloon (3.5-F, 20 mm) was advanced through the right carotid artery into the proximal left anterior descending coronary artery or left circumflex artery. Myocardial infarcts were created by inflating the angioplasty balloon for 90 min. After this period, the balloon was deflated and the artery reperfused. The MRI protocol. To define the most accurate threshold technique to assess the extent of necrotic (nonviable) myocardium, images were obtained at 24 h after MI in the first nine animals. In the subsequent four animals, images were acquired at 1 h after MI to examine the extent of the hyperenhanced region over time, after contrast injection. One hour was chosen as the time necessary to stabilize the animal after MI. All images were acquired using a 1.5-T MR scanner (CV/i, GE Medical Systems, Waukesha, Wisconsin). Animals were placed in right decubitus with a phased-array surface coil wrapped around the chest. Comparisons with infarct sizing methods. In the first nine animals, images were acquired 15 min after a 0.2-mmol/kg intravenous injection of gadolinium diethylene triamine penta-acetic acid (Gd-DTPA) (Magnevist, Berlex (12) . The inversion recovery time (TI) was fixed at 200 ms for the first image acquisition. Two observers evaluated the quality of the first delayed enhancement image, and adjustments to the TI were done if necessary to achieve the best contrast between the normal and infarcted myocardium. The overall measured TI was 223 Ϯ 9.2 ms. Timing delay study. The same protocol was used for the time delay study. However, for this protocol, imaging acquisition was performed repeatedly starting immediately after contrast injection and continuing until 30 min after injection. Each set of images, covering the entire heart from base to apex, was acquired in ϳ6 min. A total of five sets of images, each containing eight to nine short-axis images, were obtained from each animal (n ϭ 4). Small adjustments in TI were made to null the signal intensity from normal myocardium at different time points after contrast injection. The TI changed from 193.8 Ϯ 6.3% to 212.5 Ϯ 16.1% at 6 and 30 min after contrast injection, respectively (p ϭ NS).
Analysis of MRI data. COMPARISON OF INFARCT SIZING METHOD STUDY.
To determine the most accurate technique of measuring infarct size by CE-MRI, images were transferred to a SUN workstation (Sun Microsystems, Santa Clara, California) and analyzed using a custom research software package (Cine Tool, GE Medical Systems). Endocardial and epicardial contours were traced manually. Once the myocardial contours were identified, infarct areas were traced manually by two different observers using both a visual qualitative approach and objective semi-automatic thresholding techniques. Various criteria based on the signal intensities of the normal and infarcted myocardium were used to semi-automatically threshold the infarct (Fig. 1) .
N-STANDARD DEVIATIONS ABOVE REMOTE.
With this technique, the mean and standard deviation of the signal intensity from the remote (noninfarcted) myocardium region of interest was determined, and infarcted regions were defined as areas presenting signal intensities above a certain number of standard deviations from the mean of the remote. Measurements were done using 1, 2, 3, 4, 5, and 6 standard deviations above the remote mean ( Fig. 1) (1,9).
FULL-WIDTH AT HALF-MAXIMUM (FWHM).
Measurements were also done based on FWHM criterion (13, 14) . The user clicked in the hyperenhanced region to provide a seed point, and a multi-pass region-growing algorithm was used to identify the infarct boundaries by using the FWHM criterion ( Fig. 1 hyperenhanced area. Contouring was performed based on subjective visual identification of the infarct border. Timing delay study. The most accurate method of measuring infarct size determined from the previous study was then employed to calculate MI size at different delay times in four additional animals. All measurements of infarct size were expressed as a percentage of LV volume, given by the sum of the volume of the hyperenhanced regions for all slices divided by the sum of the LV myocardial crosssectional volumes for all slices. Postmortem measurements. After image acquisition, animals were euthanized. The heart was excised and sectioned into 8-mm-thick short-axis slices and incubated in 2,3,5-triphenyltetrazolium chloride (TTC) for 20 min at 38°C to delineate viable myocardium (15 Figure 2A shows excellent correspondence of the infarct size measured by delayed CE-MRI images and TTC pathology. The mean infarct size by TTC was 13.5 Ϯ 2.6% of the LV volume.
RESULTS
Comparison of infarct sizing method study. Table 1 summarizes the results of MI size measured by different thresholding techniques, compared with postmortem infarct extent. Compared with the postmortem data, the best correlation was achieved with MRI measurements based on the FWHM thresholding technique (y ϭ 1.1x ϩ 2.3; r 2 ϭ 0.94) (Fig. 2A) . Regression and Bland-Altman analysis confirmed the superiority of the FWHM technique (bias of 4.1% of LV; p Ͻ 0.001) (Fig. 2B) , compared with the other semi-automatic thresholding techniques tested (Fig. 3) . Figure 2C demonstrates the results of Bland-Altman analysis of interobserver reproducibility from semiautomatic and visual techniques. A much better reproducibility was achieved with FWHM compared with visual techniques (bias of Ϫ0.1% and Ϫ3.4% of LV for FWHM and visual measuring techniques, respectively). Timing delay study. Infarct size measurements from delayed enhancement images acquired with different delay times were segmented using the FWHM criterion. There was no significant difference in MI size (as percentage of LV volume) between different delay times after contrast injection (from 15.2 Ϯ 2.9% to 14.5 Ϯ 4.2% at 6 and 30 min after contrast injection, respectively; p ϭ NS). Figure 4 depicts delay CE images at five different time points after contrast injection, from three different animals, Figure 1 . Delayed enhancement images and semi-automatic techniques using different criteria to quantify myocardial infarct (MI) extension: 1) the full-width at half-maximum (FWHM) criterion-an initial region is determined to grow to include all pixels with signal intensity (SI) Ͼ50% of a user selected point. The maximum signal intensity (MX) inside this initial region is then determined, and the final MI extent is defined as the area presenting with a signal intensity 50% above the maximum of the initial region (MI ϭ MX * 0.5). 2) n-standard deviation (SD) criteria-the mean Ϯ SD of remote signal intensity (RI) under the yellow circle was determined. The extent of MI was defined as areas presenting with signal intensities above the mean value from the remote (MI ϭ RI ϩ SD). Measurements were done using 1, 2, 3, 4, 5, and 6 SD above the mean value.
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Accurate Infarct Size Measurement With CE-MRI demonstrating excellent concordance of infarct size measurements over time. Indeed, there was high agreement of MI size between the first set of images until 30 min after contrast injection (y ϭ 1x Ϫ 0.8; r 2 ϭ 0.97, when measurements obtained at 6 and 30 min were compared). Results were confirmed by Bland-Altman analysis (bias of Ϫ0.2% of LV) (Fig. 5) .
DISCUSSION
This study was designed to identify an accurate and objective method to measure infarct size from delayed CE-MRI scans. Our results can be summarized as follows: 1) the semi-automatic thresholding technique based on the FWHM criterion is an accurate and reproducible segmentation method to define infarct size on delayed CE images; 2) when using an accurate objective segmentation criterion, the delay time of image acquisition after contrast injection is not an important factor in the accuracy of infarct size measurements; and 3) using an accurate method to describe delayed hyperenhanced regions, no significant overestimation of the infarct size is observed compared with postmortem. CE-MRI for myocardial viability. The extent of MI and the ability to differentiate viable from nonviable tissue are important variables for treatment decision-making. In cardiology, measurements of infarct size by CE-MRI have been validated as prognostic indicators after acute MI (3). However, there is ongoing debate regarding the potential overestimation by the CE-MRI technique to assess local viability and contractile functional recovery after an acute event or treatment intervention (2, 5, 8) .
Although delayed contrast hyperenhancement has been shown to accurately reflect myocellular necrosis, and therefore to be a definite marker of absent myocardial viability on ex vivo imaging, studies have reported an overestimation of infarct size (7, 17) . More specifically, some studies have demonstrated improvement in circumferential shortening between one and seven weeks after MI in regions presenting with delayed hyperenhance- ment (5), and others have confirmed this inotropic response in up to 41% of hyperenhanced segments (18), suggesting viability. A potential explanation of these findings is the presence of a nontransmural infarction. In this regard, Garot et al. (19) have shown that the improvement in contractile function in regions of hyperenhancement are related to the presence of nontransmural infarction, suggesting a tethering to neighboring viable regions. Additionally, Kim et al. (1) demonstrated that hyperenhanced regions tend to decrease in the range of approximately three-fold from three days to eight weeks after MI. This shrinkage effect can lead to erroneous interpretation in the differentiation of nontransmural (defined as Ͻ50% of LV wall extension) from transmural (Ͼ50% of LV wall) at the acute phase of MI. These data combined support the need for an accurate technique to measure the extent of the necrotic area at the acute phase of MI. The reasons for infarct size overestimation by MRI are not completely understood. Partial volume effects intrinsic to slice thickness limitation are likely responsible for most of the infarct size overestimation. Potential mechanisms might also include the possibility that myocardial edema without cell necrosis could produce late tissue hyperenhancement through an increase in the extracellular distribution of the contrast agent (20, 21) . In theory, an interstitial water increase due to plasma infiltration after the hyperemic stage of acute MI could explain the infarct size overestimation observed in clinical and experimental studies. However, the presence of extracellular edema is difficult to document, and its magnitude is even harder to quantify. Comparison of infarct size measured from short-axis images by delayed contrast-enhanced magnetic resonance imaging (MRI) using different techniques. The arrow demonstrates the border zone, areas with partial enhancement on the edge of the infarct, which may lead to visual ambiguity in assessing the delayed hyperenhanced area. The infarcted region was delineated by the different techniques using different criteria, as shown by contours in red: 1 ϭ visual; 2 ϭ standard deviation (1 SD); and 3 ϭ full-width at half-maximum (FWHM). Significant variability among segmentation methods is noted, especially related to the inclusion of the border zone on the analysis. The MRI infarct size was compared with postmortem measurements (triphenyltetrazolium chloride [TTC] pathology). Accurate method for infarct sizing. Our study supports the importance of choosing an accurate technique to measure infarct size by CE-MRI. As shown in Table 1 , important variations in MI size measurements were observed in our study when using different thresholds for myocardial hyperenhancement (bias from 4.1 Ϯ 1.1% to 22.8 Ϯ 3.2% of LV for FWHM and 1 standard deviation criteria, respectively).
Our results illustrate the ability of the FWHM criterion to accurately measure infarct size by CE-MRI, compared with the other semi-automatic criteria. Most of the semiautomatic techniques previously published utilized the signal intensity of areas outside the infarct to define hyperenhanced regions. Surface coil intensity variations may confound the segmentation criteria when using a remote region to calculate the segmentation threshold. The FWHM criterion is based solely on the signal intensity inside the infarcted area. Therefore, even in the case of spatial variations in intensity, the boundary determined by this approach does not change, as it is relative to the local infarct signal maximum. Consequently, this approach should be less susceptible to surface coil intensity variations (Fig. 1) .
Measurements using the semi-automatic FWHM technique demonstrate a reduction in interobserver variability compared with non-automatic visual techniques (bias of Ϫ3.4 and Ϫ0.1% of LV for Bland-Altman repeatability analysis for visual and FWHM techniques, respectively) (Fig. 4) . These results reinforce the importance of using objective techniques to reduce the possibility of human error.
Even when using the most accurate technique-FWHM-differences in infarct size measured by CE-MRI and at postmortem were still observed. This can be partly explained by differences between the two techniques: MRI infarct size measurements are based on the extension of the contrast (Gd-DTPA) penetration into the necrotic tissue, whereas the TTC staining technique is related to the extension of tissue capable of reacting to the stain (TTC).
Also, problems with the TTC staining technique should be considered. For example, potential limitations of slicing the anatomic piece preceding the TTC staining are intrinsic to this method; TTC staining requires a thermalconditioning step that can dehydrate the myocardium and consequently alter the infarct configuration, making it difficult to accurately delineate the infarct's true dimensions. Finally, as a result of the thermal-conditioning step, myocardial dehydration can lead to imprecise weighting of the slices, as well as inaccuracies in infarct size measurements normalized by LV mass. Delayed time study. In our study, no significant differences in MI extent were noted among CE-MRI measurements performed between 6 and 30 min after contrast injection. These results support the findings of Mahrholdt et al. (10) , who reported that infarct size measured as the hyperenhanced area on CE-MRI does not change between 10 and 30 min after contrast. Conversely, our findings diverge from another recent report by Oshinski et al. (9) , who found a decrease from 60% of LV at 3 min to 30% of LV at 40 min after contrast injection.
The different results found in our study and the study by Oshinski et al. (9) can be partly related to differences in species, specific collateral flow, or edema formation secondary to different degrees of reperfusion injury (22) . In addition, these discrepancies could be due to differences in the MRI pulse sequences utilized in those studies (12) . The importance of the TI (delay time between the inversion pulse and data acquisition) to null the normal and noninfarcted myocardium has been emphasized in past studies (12) . In our study, TI adjustments were performed for adequate image acquisition (Fig. 4) .
Furthermore, our study highlights a new and important factor: the use of objective criteria to delineate the extension of hyperenhanced myocardium defined by CE-MRI. As shown by our findings, subjective measurements demonstrated a variance as high as Ϯ300% (from 6.0 Ϯ 2.1 to 22.8 Ϯ 3.2 for bias of 3 and 1 standard deviation techniques, respectively) among different methods. These findings reinforce the importance of choosing an accurate technique to measure infarct size in a clinical setting. Conclusions. This study documents the accuracy and reproducibility of the semi-automatic technique based on the FWHM criterion to measure infarct size by CE-MRI. In addition, the study demonstrates that by using an objective segmentation technique, the delay time after contrast injection is not an important factor to the accuracy of infarct size measurements by CE-MRI. Finally, our results suggest that future studies using CE-MRI to measure the extent of MI should consider the use of the FWHM criterion. These findings might have important implications to the interpretation of CE-MRI methods to measure infarct size in a clinical setting.
